Information Technology Reference
In-Depth Information
Perspectives on Opportunities and Challenges: Topic Introduction and ICH
Update
. FDA Advisory Committee for Pharmaceutical Science and Clinical
Pharmacology.
Polizzi, M.A. and García-Muñoz, S. (2011) 'A framework for
in-silico
formulation
design using multivariate latent variable regression methods',
Int. J. Pharm.
,
418: 235-42.
Rathore, A.S. and Mhatre, R. (eds) (2009)
Quality by Design for
Biopharmaceuticals
. Hoboken, NJ: John Wiley & Sons, Inc.
Reklaitis, G.V. (2013)
Comprehensive Quality by Design for Pharmaceutical
Product Development and Manufacture
. Hoboken, NJ: John Wiley & Sons,
Inc.
Rossi, T. and Braggio, S. (2011) 'Quality by Design in lead optimization: a new
strategy to address productivity in drug discovery',
Curr. Opin. Pharmacol.
,
11: 515-20.
Rouiller, Y. , Solacroup, T. , Deparis, V. , Barbafi eri, M., Gleixner, R., et al. (2012)
'Application of Quality by Design to the characterization of the cell culture
process of an Fc-Fusion protein',
Eur. J. Pharm. Biopharm.
, 81: 426-37.
Shah, R.B. (2009)
Quality by Design in Pharmaceutical Manufacturing
. Chicago,
IL: AAPS Annual Meeting and Exposition.
Short, S.M., Codgill, R.P., Drennen III, J.K., and Anderson, C.A. (2011)
'Performance-based quality specifi cations: the relationship between process
critical control parameters, critical quality attributes, and clinical performance',
J. Pharm. Sci.
, 100(4): 1566-75.
Undey, C., Low, D., Menezes, J.C., and Koch, M. (eds) (2012)
PAT Applied in
Biopharmaceutical Process Development and Manufacturing
. Biotechnology
and Bioprocessing Series, vol. 33. Boca Raton, FL: CRC Press, Taylor &
Francis Group.
Verma, S., Lan, Y. , Gokhale, R., and Burgess, D.J. (2009) 'Quality by Design
approach to understand the process of nanosuspension preparation',
Int. J.
Pharm.
, 377: 185-98.
Vogt, F.G. and Kord, A.S. (2011) 'Development of Quality by Design analytical
methods',
J. Pharm. Sci.
, 100(3): 797-812.
Woodcock, J. (2004) 'The concept of pharmaceutical quality',
Am. Pharm. Rev.
,
Nov/Dec: 1-3.
Wu, H., White, M., and Khan, M.A. (2011) 'Quality by Design (QbD): an
integrated process analytical technology (PAT) approach for a dynamic
pharmaceutical co-precipitation process characterization and process design
space development',
Int. J. Pharm.
, 405: 63-78.
Xu, X., Khan, M.A., and Burgess, D.J. (2011) 'A Quality by Design (QbD) case
study on liposomes containing hydrophilic API: I: Formulation, processing
design and risk assessment',
Int. J. Pharm.
, 419: 52-9.
Xu, X., Khan, M.A., and Burgess, D.J. (2012) 'A Quality by Design (QbD) case
study on liposomes containing hydrophilic API: II: Screening of critical
variables, and establishment of design space at laboratory scale',
Int. J.
Pharm.
, 423: 543-53.
Yu, L.X. (2008) 'Pharmaceutical Quality by Design: product and process
development, understanding and control',
Pharm. Res.
, 25(4): 781-91.
Search WWH ::
Custom Search